6550--FY25: VISN 8 Lab-Molecular Pathogen Detection BPA
Closed Special Notice Posted
Not the latest version. See the latest pre-solicitation from .
- Solicitation number
- 36C24824Q1589
- Agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs (VA) Veterans Health Administration, Veterans Integrated Service Network 8 (VISN 8) has issued a Special Notice for a Request for Information (RFI) related to the supply of Molecular Pathogen Detection reagents and equipment. This RFI aims to continue the use of these diagnostic testing capabilities across VISN 8 facilities, which include medical centers in Florida and Puerto Rico.
The purpose of this RFI is to gather information from potential vendors, including large businesses, service-disabled veteran-owned small businesses, veteran-owned small businesses, HUBZone small businesses, 8(a) small businesses, and women-owned or small disadvantaged businesses. The government is seeking information on the availability and capabilities of these businesses to provide the required molecular diagnostic testing platforms and associated supplies to support in-vitro diagnostic testing panels for various medical conditions. The anticipated period of performance is 5 years with four 1-year option periods, and the government intends to award this as a sole source contract if potential vendors cannot be identified. Responses to this RFI are due by September 6, 2024.
Notice text
This is a Request for Information (RFI) for a requirement to continue using Molecular Pathogen Detection reagents supply purchase with equipment lease capable of running the following in-vitro diagnostics (IVD) test/panels with accompanying verification kits for all Pathology & Laboratory Medicine Service (P&LMS) locations in VISN 08 to provide the best patient care to our Veteran population:
Gastrointestinal (GI) Panel
Meningitis/Encephalitis (ME) Panel
Joint Infection (JI) Panel
Pneumonia (PN) Panel
Blood Culture Identification (BCID) Panel
Respiratory (RP) Panel
VISN 08 Sites include: Tampa James A. Haley Veterans Hospital, Orlando VA Medical Center, Bay Pines C.W. Bill Young VA Medical Center, Gainesville North Florida/South Georgia Malcom Randall VA Medical Center, West Palm VA Medical Center, Miami VA Healthcare System, and Puerto Rico, San Juan VA Medical Center.
The multiplexed molecular diagnostic testing platforms shall provide molecular pathogen detection using the polymerase chain reaction (PCR) methodology. Additional testing and testing sites may be added based on Veteran care needs and availability. Equipment should meet or exceed the below specifications for brand name or equivalent Biomerieux Biofire FilmArray (FA) Torch Multiplex PCR system.
The Government may use the responses to this RFI for information and planning purposes. The Government also intends to make this action a sole source award, if potential vendors cannot be identified.
The anticipated period of performance of: 1 October 2024 thru 30 September 2029 with possible four one-year option periods.
This RFI will obtain information regarding the availability and capability of qualified businesses: Large Business, Service-Disabled Veteran-Owned, Small Business, Veteran-Owned Small Business, small business sources; HUB Zone 8(a), Women-Owned, or small disadvantaged business concerns; and their size classification relative to the North American Industry Classification System (NAICS) code 611710.
The responses to this announcement will assist in determining the availability of small businesses in consideration of a socio-economic set-aside.
Interested parties submitting a response to this inquiry must include the following information:
1. Name and address of company
2. Primary point of contact, including phone number and e-mail address
3. Federal Supply Schedule (FSS), if available
3. Applicable socioeconomic categories and any pertinent information, which demonstrates firm s ability to meet the requirement
4. Experience. Brief descriptions of recent and relevant projects for tasks similar to those identified in paragraph one of this document. (1 page maximum)
5. Business size (the applicable NAICS code for this requirement is 325413)
6. Product and Service Code: 6640
Responses are due no later than 6 September 2024 @ 9:00AM EST. Point of contact: Paul Jarret, paul.jarrett@va.gov.
NOTE: This RFI is for planning purposes. Issuance of this notice does not constitute any obligation on the part of the Government to procure these items or to issue a solicitation. In addition, the Government is under no obligation to pay for information submitted in response to this RFI, and responses to this notice cannot be accepted as offers. Any information that the vendor considers proprietary should be clearly marked as such.
Files
| File | Type | Posted |
|---|---|---|
| 36C24824Q1589.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6550--FY25: VISN 8 Lab-Molecular Pathogen Detection BPA | Pre-Solicitation | |
| This notice | Special Notice |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC | Veterans Integrated Service Network 20 | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| 6550--VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ | Veterans Integrated Service Network 5 | No set-aside | |
| 6550--VISN 4 Coagulation Testing | Veterans Integrated Service Network 4 | No set-aside | |
| 6640--karius test | Veterans Integrated Service Network 8 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity